Bladder cancer is the ninth most common malignancy worldwide with over 330,000 cases diagnosed every year. The standard surgical treatment offered to patients diagnosed with muscle-invasive bladder cancer or high-risk non-muscle-invasive bladder cancer is radical cystectomy with pelvic lymph node dissection. This can be performed laparoscopically, robotically, or in an open fashion. Open radical cystectomy (ORC) is considered a highly morbid procedure with an overall complication rate of 60% and a major complication rate of 13-40%. In an attempt to reduce morbidity and mortality, alternative operative technologies have been explored by surgeons worldwide. This has led to an increase in patients undergoing robotic radical cystectomy (RRC). Our recently published paper examines the early surgical outcomes and complications of patients undergoing RRC compared to those undergoing ORC.